BLSA 2024: How to Develop the Best Teams? Panel Discussion

BLSA 2024: Inclusive Pathways: Embracing Neurodiversity in Life Sciences

BLSA 2024: Overcoming Imposter Syndrome

BLSA 2024: Is a PhD worth it?

BLSA 2024: The Challenges of Benchmarking in Remuneration

BLSA 2024: The Role of Social Media in Recruitment & Career Development

BLSA 2024: How do Big Pharma and Start Ups Compete for the Right People?

BLSA 2024: UK vs USA - Recruitment Talks

MyData-TRUST: Building a Solid Foundation

One Nucleus Explainer Presentation March 2024

Genesis 23 - Keynote Presentation: Winners & Losers 2023

Genesis 2023: Does the Early-stage Biotech Funding Landscape in the UK Need Disrupting?

Genesis 2023: Innovation opportunities in Baden-Württemberg’s Healthcare sector

Genesis 2023: Advancing Innovation Through Clusters Innovation Workshop

Genesis 2023 Innovation Workshop: Getting the most from your IP Strategy

Genesis 2023: Bio Invest - Coming to the USA

Genesis 2023: Listing in London

Genesis 2023 Innovation Workshop with Cellusion

Genesis 2023: Soft-landing Opportunities for Japanese Life Science Startups and the Ecosystems

Genesis 2023 Welcome from One Nucleus - Jon Green

Genesis 23 Panel: Bio Dollar Briefing

Genesis 23 Panel: Buy, Borrow or Grow Your Own

Genesis 23 Why We Should Win This Award!

Genesis 23 Panel: Investing in Longevity – Better & More Affordable Patient Outcomes

Genesis 23 Panel Winner of the BioNewsRound Award

Genesis What Would I Like From the Life Sciences Industry

Genesis 23 Panel The Anatomy of a Great Dealmaker

Genesis 2023 Panel Incorporating Real World Evidence into R&D Strategy

Genesis 2023 Panel BioPharma Dealmaker Outlook

Genesis Conference Website Launch